Mirror Therapy as group intervention for patients after stroke - a randomised controlled trial

Mirror Therapy as group intervention for patients after stroke - a randomised controlled trial - MIRaGe

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000732

Enrollment

Registered

2011-02-17

Start date

2009-04-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I64

Interventions

Group 1: Mirror Therapy as group intervention: A mirror is placed between the two arms that movements of the non paretic arm are reflected. Thus a visual feedback is created as if the paretic arm is m

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: first supratentorial stroke with a maximum of 3 months before study entry, severe hemiparesis of the upper extremity

Exclusion criteria

Exclusion criteria: visual impairments, which may limit the participation on mirror therapy; severe cognitive and/ or language deficits which preclude them from following instruction in the group training protocol; other neurological or musculoskeletal impairments of the upper extremity not due to stroke; a severe neglect

Design outcomes

Primary

Measure	Time frame
Outcome: motor function of the upper extremity; measurement points: before the intervention (t0), after 4 weeks of intervention (t1) and 6 months after the intervention (t2) per protocol; Assessment: Fugl-Meyer-Assessment, Action Research Arm Test; Changes to protocol: Due to organisatorical reasons the follow-up assessment t1 is set on the end of the 5 week intervention period and t2 on 7 months after the intervention. Follow-up t2 discontinued due to organisatorical reasons.	—

Measure

Time frame

Outcome: motor function of the upper extremity; measurement points: before the intervention (t0), after 4 weeks of intervention (t1) and 6 months after the intervention (t2) per protocol; Assessment: Fugl-Meyer-Assessment, Action Research Arm Test; Changes to protocol: Due to organisatorical reasons the follow-up assessment t1 is set on the end of the 5 week intervention period and t2 on 7 months after the intervention. Follow-up t2 discontinued due to organisatorical reasons.

—

Secondary

Measure	Time frame
Outcome: somatosensibility, passive range of motion, pain, muscle hypertonia, activities of daily living, quality of life; measurement points: before the intervention (t0), after 4 weeks of intervention (t1) and 6 months after the intervention (t2) per protocol; Assessment: Fugl-Meyer-Assessment (somatosensibility, passive range of motion, pain), modified Ashworth Scale (muscle hypertonia), Barthel Index (activities of daily living), Stroke Impact Scale (quality of life) Changes to protocol: Due to organisatorical reasons the follow-up assessment t1 is set on the end of the 5 week intervention period and t2 on 7 months after the intervention. Follow-up t2 discontinued due to organisatorical reasons.	—

Measure

Time frame

Outcome: somatosensibility, passive range of motion, pain, muscle hypertonia, activities of daily living, quality of life; measurement points: before the intervention (t0), after 4 weeks of intervention (t1) and 6 months after the intervention (t2) per protocol; Assessment: Fugl-Meyer-Assessment (somatosensibility, passive range of motion, pain), modified Ashworth Scale (muscle hypertonia), Barthel Index (activities of daily living), Stroke Impact Scale (quality of life) Changes to protocol: Due to organisatorical reasons the follow-up assessment t1 is set on the end of the 5 week intervention period and t2 on 7 months after the intervention. Follow-up t2 discontinued due to organisatorical reasons.

—

Countries

Germany

Contacts

Public ContactHolm Thieme

Erste Europäische Schule für Physiotherapie, Ergotherapie und Logopädie, Klinik Bavaria Kreischa

holm.thieme@physiotherapie-schule-kreischa.de035206 64240

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026